Resource centre

Success Factors for Remote and Hybrid Decentralised Trials from Site, Technology and Service Provider Perspectives with a Focus on the RADIAL Study from Trials@Home

Monitoring fluctuations in psychiatric symptoms though analysis of speech

Speech analytics and natural language processing for automation of quality assurance in clinical trials

Speech biomarkers from active and passive collection of voice in Alzhiemer’s disease clinical trials

Real-World Measurement of Cognition and Mood in Frontline COVID-19 Healthcare Workers

Successful Statistical Strategies for Patient Screening and Stratification

Decentralised Trials in Psychiatry: From Feasibility to Novel Insights

Novel Digital Technologies and Biomarkers to Characterise Depression

Digital Health Event 2021: Integrating multimodal data to meet clinical challenges

Voice Technology in Clinical Trials

Virtual clinical trials: What have we learned in the era of Covid-19?

Remote Cognitive Testing and Lessons Learned During Lockdown

Wearable Technology for High-Frequency Cognitive and Mood Assessments in Depression

Elderly patients in clinical trials: addressing the evidence-practice gap

Future directions in eCOA: Innovations in high-frequency and automated voice-based testing

Pro-cognitive drug trial failures in schizophrenia: the need for cognitive screening?

Cognitive Safety: Satisfying Regulatory Requirements in a Competitive Landscape

Digital Health: Optimizing Clinical Trials with Patient-Centric Technology

Early Alzheimer’s Disease: Finding the Right Patients for Clinical Trials and Beyond

Schizophrenia Trials: Overcoming Methodological Challenges to Enhance Study Success

Leveraging Cognitive Measures in Clinical Trials

Understanding the Clinical Assessment of Abuse Potential during CNS Drug Development

Assessing Cognitive Safety of Drugs in Clinical Development